The signaling cascades of the
mitogen activated protein kinase (MAPK) family,
calcineurin/NFATc4, and PI3K/Akt/GSK3, are believed to participate in
endothelin-1 (ET-1)-induced
cardiac hypertrophy. The aim of this study was to investigate whether
KMUP-1, a synthetic
xanthine-based derivative, prevents cardiomyocyte
hypertrophy induced by ET-1 and to elucidate the underlying mechanisms. We found that in H9c2 cardiomyocytes, stimulation with ET-1 (100 nM) for 4 days induced cell
hypertrophy and enhanced expressions of hypertrophic markers, including
atrial natriuretic peptide and
brain natriuretic peptide, which were all inhibited by
KMUP-1 in a dose-dependent manner. In addition,
KMUP-1 prevented ET-1-induced intracellular
reactive oxygen species generation determined by the
DCFH-DA assay in cardiomyocytes.
KMUP-1 also attenuated phosphorylation of ERK1/2 and Akt/GSK-3β, and activation of
calcineurin/NFATc4 and RhoA/ROCK pathways induced by ET-1. Furthermore, we found that the expression of
heme oxygenase-1 (HO-1), a stress-response
enzyme implicated in cardio-protection, was up-regulated by
KMUP-1. Finally,
KMUP-1 attenuated ET-1-stimulated
activator protein-1 DNA binding activity. In conclusion,
KMUP-1 attenuates cardiomyocyte
hypertrophy induced by ET-1 through inhibiting ERK1/2,
calcineurin/NFATc4 and RhoA/ROCK pathways, with associated cardioprotective effects via HO-1 activation. Therefore,
KMUP-1 may have a role in pharmacological
therapy of
cardiac hypertrophy.